Related Experiment Video
Updated: Jun 1, 2026

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Gut bitter taste receptor signalling induces ABCB1 through a mechanism involving CCK
Tae-Il Jeon1, Young-Kyo Seo, Timothy F Osborne
1Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA.
Abstract:
T2Rs (bitter taste-sensing type 2 receptors) are expressed in the oral cavity to prevent ingestion of dietary toxins through taste avoidance. They are also expressed in other cell types, including gut enteroendocrine cells, where their physiological role is enigmatic. Previously, we proposed that T2R-dependent CCK (cholecystokinin) secretion from enteroendocrine cells limits absorption of dietary toxins, but an active mechanism was lacking. In the present study we show that T2R signalling activates ABCB1 (ATP-binding cassette B1) in intestinal cells through a CCK signalling mechanism. PTC (phenylthiocarbamide), an agonist for the T2R38 bitter receptor, increased ABCB1 expression in both intestinal cells and mouse intestine. PTC induction of ABCB1 was decreased by either T2R38 siRNA (small interfering RNA) or treatment with YM022, a gastrin receptor antagonist. Thus gut ABCB1 is regulated through signalling by CCK/gastrin released in response to PTC stimulation of T2R38 on enteroendocrine cells. We also show that PTC increases the efflux activity of ABCB1, suggesting that T2R signalling limits the absorption of bitter tasting/toxic substances through modulation of gut efflux membrane transporters.
Insights
Bitter taste receptors (T2Rs) in the gut signal through cholecystokinin (CCK) to activate ABCB1 transporters. This mechanism helps limit the absorption of dietary toxins, protecting the body.
Area of Science:
- Physiology
- Molecular Biology
- Pharmacology
Background:
- Bitter taste-sensing type 2 receptors (T2Rs) are found in the oral cavity and gut.
- Their role in gut enteroendocrine cells is not well understood.
- Previous research suggested T2R-dependent cholecystokinin (CCK) secretion limits toxin absorption, but an active mechanism was missing.
Purpose of the Study:
- To investigate the mechanism by which T2R signaling influences the absorption of dietary toxins in the intestine.
- To determine if T2R activation leads to the regulation of efflux transporters like ABCB1 (ATP-binding cassette B1).
Main Methods:
- Treated intestinal cells and mouse intestine with phenylthiocarbamide (PTC), a T2R38 agonist.
- Utilized T2R38 siRNA and a gastrin receptor antagonist (YM022) to block signaling pathways.
- Measured ABCB1 expression and efflux activity.
Main Results:
- PTC stimulation of T2R38 increased ABCB1 expression in intestinal cells and mouse intestine.
- This induction was significantly reduced by T2R38 siRNA and YM022 treatment.
- PTC also enhanced the efflux activity of ABCB1, indicating increased transporter function.
Conclusions:
- Gut ABCB1 expression and function are regulated by T2R signaling via CCK/gastrin pathways.
- This T2R-mediated modulation of gut efflux transporters limits the absorption of bitter-tasting or toxic substances.
Related Concept Videos
The Physiology of Taste
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Gustation
IP3/DAG Signaling Pathway
Endocrine Signaling

